Latest Biodefense Stories
CHICAGO, Nov. 9, 2010 /PRNewswire/ -- Advanced Life Sciences Holdings, Inc.
PRINCETON, N.J., Nov. 2, 2010 /PRNewswire-FirstCall/ -- Soligenix, Inc.
ANNAPOLIS, Md., Oct. 21 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company's Board of Directors has appointed Eric I.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced three new contracts to fund research on vaccines to protect against emerging infectious diseases and biological threats that could be used in a terror attack.
CHICAGO, Oct. 4 /PRNewswire/ -- Advanced Life Sciences Holdings, Inc.
PRINCETON, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today the publication of an article online in Vaccine.
CHICAGO, Aug. 24 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc.
CHANTILLY, Va., Aug. 6 /PRNewswire/ -- Rashid Chotani, M.D., M.P.H., has joined TASC, Inc. as director of Chemical-Biological Defense Programs. In this role, Chotani will lead chemical and biological programs that support the Defense Threat Reduction Agency (DTRA), U.S.
ANNAPOLIS, Md., July 8 /PRNewswire-FirstCall/ -- PharmAthene, Inc.
PRINCETON, N.J., June 25 /PRNewswire-FirstCall/ -- Soligenix, Inc.
- A gift; a largess; a gratuity; a present; a dole.